Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Total Current Liabilities (2016 - 2025)

Rhythm Pharmaceuticals (RYTM) has disclosed Total Current Liabilities for 10 consecutive years, with $105.9 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 8.29% to $105.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $105.9 million through Dec 2025, down 8.29% year-over-year, with the annual reading at $105.9 million for FY2025, 8.29% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $105.9 million at Rhythm Pharmaceuticals, up from $104.3 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $129.5 million in Q2 2025, with the low at $16.8 million in Q1 2021.
  • Average Total Current Liabilities over 5 years is $61.8 million, with a median of $48.7 million recorded in 2022.
  • Peak annual rise in Total Current Liabilities hit 180.56% in 2022, while the deepest fall reached 8.33% in 2022.
  • Over 5 years, Total Current Liabilities stood at $43.4 million in 2021, then dropped by 8.33% to $39.8 million in 2022, then soared by 38.67% to $55.2 million in 2023, then soared by 109.26% to $115.5 million in 2024, then decreased by 8.29% to $105.9 million in 2025.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $105.9 million, $104.3 million, and $129.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.